CULLEN/FROST BANKERS, INC. - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 268 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 3.49 and the average weighting 0.1%.

Quarter-by-quarter ownership
CULLEN/FROST BANKERS, INC. ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$15,340
-23.4%
5000.0%0.00%
Q2 2023$20,035
-1.8%
5000.0%0.00%
Q1 2023$20,405
+5.7%
5000.0%0.00%
Q4 2022$19,305
-28.5%
5000.0%0.00%
-100.0%
Q3 2022$27,000
-6.9%
5000.0%0.00%0.0%
Q2 2022$29,000
-23.7%
5000.0%0.00%0.0%
Q1 2022$38,000
+26.7%
5000.0%0.00%0.0%
Q4 2021$30,000
+7.1%
5000.0%0.00%0.0%
Q3 2021$28,000
-6.7%
5000.0%0.00%0.0%
Q2 2021$30,000
-14.3%
5000.0%0.00%0.0%
Q1 2021$35,000
+16.7%
5000.0%0.00%0.0%
Q4 2020$30,0000.0%5000.0%0.00%0.0%
Q3 2020$30,000
+15.4%
5000.0%0.00%0.0%
Q2 2020$26,000
+52.9%
5000.0%0.00%0.0%
Q1 2020$17,000
-26.1%
5000.0%0.00%0.0%
Q4 2019$23,000
+21.1%
5000.0%0.00%0.0%
Q3 2019$19,000
-13.6%
5000.0%0.00%0.0%
Q2 2019$22,000
+15.8%
5000.0%0.00%0.0%
Q1 2019$19,000
-91.1%
500
-77.3%
0.00%
-88.9%
Q3 2014$213,0002,2000.01%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Key Colony Management, LLC 134,600$13,045,00011.31%
Biondo Investment Advisors, LLC 279,717$27,110,0008.33%
GILDER GAGNON HOWE & CO LLC 3,177,130$307,927,0004.48%
DARUMA CAPITAL MANAGEMENT LLC 814,470$78,938,0003.47%
MAGEE THOMSON INVESTMENT PARTNERS LLC 126,022$12,214,0003.01%
NEXT CENTURY GROWTH INVESTORS LLC 768,396$74,472,0002.63%
MARXE AUSTIN W & GREENHOUSE DAVID M 180,000$17,446,0002.38%
Lisanti Capital Growth, LLC 48,280$4,679,0002.35%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 79,017$7,658,0002.00%
Atika Capital Management LLC 21,500$2,084,0001.60%
View complete list of PACIRA PHARMACEUTICALS INC shareholders